Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosal Immunity and Diagnosis of SARS-CoV-2 Variants
NCT05858502Recruiting
- Sponsor
- Institut Pasteur
- Start
- Dec 2023
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Institut Pasteur. Primary endpoint: Characterization of SARS-CoV-2 infection and host response, particularly mucosal immunity at 12 months. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05858502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858502.